Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ABBV-400 in combination with fluorouracil, leucovorin, and bevacizumab for adults with unresectable metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ABBV-400
• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)

Snippet

Sponsor: AbbVie | Conditions: Unresectable Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING